HEADLINE: Lack of Swiss-specific import controls for therapeutic products posed safety risks.
Swissmedic import authorisation; GMP compliance; batch release testing; Swiss labelling
Refusal of entry; fines up to CHF 200,000; criminal prosecution
Mandatory Deadline: Ongoing — authorisation required before import
Affected HS Codes: 3001, 3002, 3003, 3004, 3005, 3006, 9018, 9019, 9020, 9021, 9022
Issuing Authority: Swiss Agency for Therapeutic Products (Swissmedic)